The Claim

In adults with metabolic dysfunction-associated steatotic liver disease, the Framingham Risk Score and Pooled Cohort Equation systematically overestimate cardiovascular risk in the highest predicted deciles and underestimate it in the lowest predicted deciles, resulting in miscalibration that impairs their clinical utility.

Source: Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
52score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

In people with metabolic dysfunction-associated steatotic liver disease, two commonly used heart disease risk calculators consistently give wrong predictions: they overstate risk for those predicted to be at highest risk and understate risk for those predicted to be at lowest risk, making them unreliable for clinical decisions.

See the scientific wording

In adults with metabolic dysfunction-associated steatotic liver disease, the Framingham Risk Score and Pooled Cohort Equation are significantly miscalibrated, overestimating cardiovascular risk in the highest predicted deciles and underestimating it in the lowest deciles, suggesting they cannot reliably guide clinical decisions in this population.

Why this might work

Fat buildup in the liver changes how the body processes fats and triggers chronic inflammation, which damages blood vessels in ways that standard risk calculators don't account for, making them inaccurate for people with this liver condition.

Suggested mechanismbased on 1 study

What the research says

1 study

  1. Study: Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease.

    For people with fatty liver disease, common heart risk calculators often get it wrong — telling some high-risk people they’re low-risk and some low-risk people they’re high-risk. This study proves those calculators are not reliable for this group.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.